Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology

J Allergy Clin Immunol. 2012 Aug;130(2):311-24. doi: 10.1016/j.jaci.2012.04.046. Epub 2012 Jun 17.

Authors

Mark Ballow¹, Cezmi A Akdis, Thomas B Casale, Andrew J Wardlaw, Sally E Wenzel, Zuhair Ballas, Jan Lötvall

Affiliation

¹ Division of Allergy, Immunology & Pediatric Rheumatology, SUNY Buffalo School of Medicine, Buffalo, NY 14222, USA. markbal.aird@gmail.com

PMID: 22713596
DOI: 10.1016/j.jaci.2012.04.046

No abstract available

MeSH terms

Adrenal Cortex Hormones / administration & dosage
Adrenal Cortex Hormones / therapeutic use
Antibodies, Bispecific / administration & dosage
Antibodies, Bispecific / therapeutic use
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / therapeutic use
Asthma / drug therapy*
Asthma / immunology
Calcineurin / immunology
Calcineurin Inhibitors
Cytokines / immunology
Desensitization, Immunologic
Humans
Hypersensitivity / drug therapy*
Hypersensitivity / immunology
Immunologic Factors / administration & dosage
Immunologic Factors / therapeutic use
Peroxisome Proliferator-Activated Receptors / antagonists & inhibitors
Peroxisome Proliferator-Activated Receptors / immunology
Protein Kinase Inhibitors / administration & dosage
Protein Kinase Inhibitors / therapeutic use
Receptors, Antigen, T-Cell / antagonists & inhibitors
Receptors, Antigen, T-Cell / immunology
Signal Transduction / drug effects
Signal Transduction / immunology
Th2 Cells / immunology
Th2 Cells / pathology

Substances

Adrenal Cortex Hormones
Antibodies, Bispecific
Antibodies, Monoclonal
Calcineurin Inhibitors
Cytokines
Immunologic Factors
Peroxisome Proliferator-Activated Receptors
Protein Kinase Inhibitors
Receptors, Antigen, T-Cell
Calcineurin